Basit öğe kaydını göster

Patient-Reported Outcomes (Pros) Of Cemiplimab Vs Chemotherapy In Advanced Non-Small Cell Lung Cancer (Ansclc): EMPOWER-Lung 1 Histology Subgroups

dc.contributor.authorSezer, A.
dc.contributor.authorKilickap, S.
dc.contributor.authorGumus, M.
dc.contributor.authorBondarenko, I.
dc.contributor.authorOzguroglu, M.
dc.contributor.authorGogishvili, M.
dc.contributor.authorHe, X.
dc.contributor.authorGullo, G.
dc.contributor.authorRietschel, P.
dc.contributor.authorQuek, R.
dc.date.accessioned2023-01-02T07:44:13Z
dc.date.available2023-01-02T07:44:13Z
dc.date.issued2022
dc.identifier.issn0923-7534en_US
dc.identifier.urihttps://reader.elsevier.com/reader/sd/pii/S092375342203157X?token=CE440C703142DFD2F8552550E5FFE69B6C4BADA16CE67888407EC9305C61FAC843557A9FCF93829AF385621391C51EF6&originRegion=eu-west-1&originCreation=20230102074310
dc.identifier.urihttp://hdl.handle.net/11727/8489
dc.language.isoengen_US
dc.relation.isversionof10.1016/j.annonc.2022.07.1306en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titlePatient-Reported Outcomes (Pros) Of Cemiplimab Vs Chemotherapy In Advanced Non-Small Cell Lung Cancer (Ansclc): EMPOWER-Lung 1 Histology Subgroupsen_US
dc.typeconferenceObjecten_US
dc.relation.journalANNALS OF ONCOLOGYen_US
dc.identifier.volume33en_US
dc.identifier.issue7en_US
dc.identifier.startpage1089en_US
dc.identifier.endpage1089en_US
dc.identifier.wos000866211601445en_US


Bu öğenin dosyaları:

Thumbnail
Ad:
128.pdf
Boyut:
103.9Kb
Biçim:
PDF
Göster/Aç

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster